NSEAmendment to AOA/MOA31 Jul 2026 · 31 Jul 2026, 05:36 pm
Amendment to AOA/MOA
Ajooni Biotech Limited · AJOONI
✦ AI Summary
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, where the members have approved the increase in Authorised Share Capital and Amendment of Capital Clause of the Memorandum of Association.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Attachments (1)
📄pdf
Download →
AJOONI_31072026173529_Increase_in_Auth_Capital_and_Amendment_in_Capital_CLause.pdf
View document text
AJOONI BIOTECH LIMITED
Regd. Office: D-118, Industrial Area, Phase VII, Mohali-160055 (Pb.)
Corp Office: H.No 1769, Phase 3B2, Mohali-160059
Phone: 0172-5020758-69 Website: www.ajoonibiotech.com
E-mail: ajooni.biotech@gmail.com / info@ajoonibiotech.com
CIN: L85190PB2010PLC040162
Date: July 31, 2026
National Stock Exchange of India Ltd
Exchange Plaza, Plot no. C/1, G Block,
Bandra-Kurla Complex, Bandra (E)
Mumbai - 400051
Dear Sir / Madam,
Subject: Disclosure of events pursuant to Regulation 30 (2) of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015
SYMBOL: AJOONI
Ref: Amendment of Capital Clause of the Memorandum of Association of the Company.
We would like to inform that the members of the company, at the 16th Annual General Meeting of
the company held on Wednesday, 29th July, 2026 at 11.00 a.m. held through video conferencing, by
passing special resolution has approved the increase in Authorised Share Capital and Amendment
of Capital Clause of the Memorandum of Association of the Company. The existing Clause V of the
Memorandum of Association will be altered and substituted with the following Clause V:
The Authorised Share Capital of the Company is Rs. 70,00,00,000/- (Rupees Seventy Crores Only) divided
into 35,00,00,000 (Thirty Five Crores) Equity Shares of having face value of Rs. 2/- (Rupees Two Only)
each.
It is to further inform that voting results along with scrutinizer report for the 16th Annual General
Meeting of the company held on Wednesday, 29th July, 2026 at 11.00 am held through video
conferencing were declared on 31st July 2026 for the purpose of ascertaining approval of resolution
of Amendment of Capital Clause of the Memorandum of Association of the Company.
Kindly take the same on your records.
Thanking You,
Yours Truly,
For Ajooni Biotech Limited
Jasjot Singh
Managing Director
DIN: 01937631
Works: G,T, Road, Khanna- 141401 (Punjab) INDIA